Braslyn Ltd. - Net Worth and Insider Trading

Braslyn Ltd. Net Worth

The estimated net worth of Braslyn Ltd. is at least $187 Million dollars as of 2024-05-08. Braslyn Ltd. is the 10% Owner of Mirati Therapeutics Inc and owns about 3,135,966 shares of Mirati Therapeutics Inc (MRTX) stock worth over $184 Million. Braslyn Ltd. is also the 10% Owner of Inseego Corp and owns about 761,483 shares of Inseego Corp (INSG) stock worth over $3 Million. Details can be seen in Braslyn Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Braslyn Ltd. has not made any transactions after 2021-03-10 and currently still holds the listed stock(s).

Transaction Summary of Braslyn Ltd.

Braslyn Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Braslyn Ltd. owns 6 companies in total, including Pandion Therapeutics Inc (PAND) , Mirati Therapeutics Inc (MRTX) , and Inseego Corp (INSG) among others .

Click here to see the complete history of Braslyn Ltd.’s form 4 insider trades.

Insider Ownership Summary of Braslyn Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
PAND	Pandion Therapeutics Inc	2020-07-21	10 percent owner
MRTX	Mirati Therapeutics Inc	2021-03-10	10 percent owner
INSG	Inseego Corp	2020-12-16	10 percent owner
		2019-03-04	10 percent owner
		2018-10-26	10 percent owner
		2021-08-10	10 percent owner

Braslyn Ltd. Latest Holdings Summary

Braslyn Ltd. currently owns a total of 2 stocks. Among these stocks, Braslyn Ltd. owns 3,135,966 shares of Mirati Therapeutics Inc (MRTX) as of March 10, 2021, with a value of $184 Million and a weighting of 98.42%. Braslyn Ltd. also owns 761,483 shares of Inseego Corp (INSG) as of December 16, 2020, with a value of $3 Million and a weighting of 1.58%.

Latest Holdings of Braslyn Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MRTX	Mirati Therapeutics Inc	2021-03-10	3,135,966	58.70	184,081,204
INSG	Inseego Corp	2020-12-16	761,483	3.89	2,958,361

Holding Weightings of Braslyn Ltd.

Braslyn Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Braslyn Ltd. has made a total of 4 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 12,381 shares on March 10, 2021, which brought Braslyn Ltd. around $2 Million.

According to the SEC Form 4 filings, Braslyn Ltd. has made a total of 1 transactions in Inseego Corp (INSG) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Inseego Corp is the sale of 238,517 shares on December 16, 2020, which brought Braslyn Ltd. around $37 Million.

Insider Trading History of Braslyn Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Braslyn Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Braslyn Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Braslyn Ltd. is -39.64%. GuruFocus also compares Braslyn Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Braslyn Ltd. within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Braslyn Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Braslyn Ltd.

Average Return

Average return per transaction

Outperforming Transactions

5 out of 10 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-1.9
Relative Return to S&P 500(%)	-3.94

Braslyn Ltd. Ownership Network

Ownership Network List of Braslyn Ltd.

No Data

Ownership Network Relation of Braslyn Ltd.

Braslyn Ltd. Owned Company Details

What does Pandion Therapeutics Inc do?

Who are the key executives at Pandion Therapeutics Inc?

Braslyn Ltd. is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Boxer Capital, Llc , and 10 percent owner Polaris Partners VIII, L.P. .

Pandion Therapeutics Inc (PAND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pandion Therapeutics Inc Insider Transactions

No Available Data

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Braslyn Ltd. is the 10 percent owner of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , EVP & Chief Commercial Officer Benjamin Hickey , and Interim CFO Aaron Ondrey .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

Over the past 18 months, Braslyn Ltd. made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirati Therapeutics Inc Insider Transactions

No Available Data

What does Inseego Corp do?

Who are the key executives at Inseego Corp?

Braslyn Ltd. is the 10 percent owner of Inseego Corp. Other key executives at Inseego Corp include 10 percent owner Joseph Lewis , 10 percent owner Tavistock Financial, Llc , and Chief Financial Officer Steven Gatoff .

Inseego Corp (INSG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inseego Corp (INSG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inseego Corp (INSG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inseego Corp (INSG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inseego Corp Insider Transactions

No Available Data

What does Solid Biosciences Inc do?

Who are the key executives at Solid Biosciences Inc?

Braslyn Ltd. is the 10 percent owner of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include director & Chief Executive Officer Ilan Ganot , director & 10 percent owner Ra Capital Healthcare Fund Lp , and director & 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Solid Biosciences Inc (SLDB) Insider Trades Summary

Over the past 18 months, Braslyn Ltd. made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 3,753 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 462 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 462 shares. During the past 18 months, 26,233 shares of Solid Biosciences Inc (SLDB) were sold and 4,314,873 shares were bought by its insiders, resulting in a net purchase of 4,288,640 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Solid Biosciences Inc Insider Transactions

No Available Data

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Braslyn Ltd. is the 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Braslyn Ltd. made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Esperion Therapeutics Inc Insider Transactions

No Available Data

What does Tango Therapeutics Inc do?

Who are the key executives at Tango Therapeutics Inc?

Braslyn Ltd. is the 10 percent owner of Tango Therapeutics Inc. Other key executives at Tango Therapeutics Inc include other: See remarks Mva Investors, Llc , 10 percent owner Third Rock Ventures Iv, L.p. , and See Remarks Douglas Barry .

Tango Therapeutics Inc (TNGX) Insider Trades Summary

Over the past 18 months, Braslyn Ltd. made no insider transaction in Tango Therapeutics Inc (TNGX). Other recent insider transactions involving Tango Therapeutics Inc (TNGX) include a net purchase of 2,750,000 shares made by Boxer Capital, Llc , a net sale of 15,878 shares made by Adam Crystal , and a net sale of 210,000 shares made by Mva Investors, Llc .

In summary, during the past 3 months, insiders sold 372,500 shares of Tango Therapeutics Inc (TNGX) in total and bought 0 shares, with a net sale of 372,500 shares. During the past 18 months, 629,017 shares of Tango Therapeutics Inc (TNGX) were sold and 2,975,000 shares were bought by its insiders, resulting in a net purchase of 2,345,983 shares.

Tango Therapeutics Inc (TNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tango Therapeutics Inc Insider Transactions

No Available Data

Braslyn Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Braslyn Ltd.. You might contact Braslyn Ltd. via mailing address: Cay House, Ep Taylor Drive N7776, Lyford Cay, New Providence C5 00000.

Discussions on Braslyn Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.